A - Human Necessities – 61 – L
Patent
A - Human Necessities
61
L
A61L 27/54 (2006.01) A61F 2/06 (2006.01) A61K 31/436 (2006.01) A61K 47/10 (2006.01) A61K 47/22 (2006.01) A61L 27/34 (2006.01) A61L 31/14 (2006.01) A61L 31/16 (2006.01) A61M 37/00 (2006.01)
Patent
CA 2504258
Medical devices, and in particular implantable medical devices, may be coated to minimize or substantially eliminate a biological organism's reaction to the introduction of the medical device to the organism. The medical devices may be coated with any number of biocompatible materials. Therapeutic drugs, agents or compounds may be mixed with the biocompatible materials and affixed to at least a portion of the medical device. These therapeutic drugs, agents or compounds may also further reduce a biological organism's reaction to the introduction of the medical device to the organism. In addition, these therapeutic drugs, agents and/or compounds may be utilized to promote healing, including the formation of blood clots. The drugs, agents, and/or compounds may also be utilized to treat specific diseases, including vulnerable plaque. Therapeutic agents may also be delivered to the region of a disease site. In regional delivery, liquid formulations may be desirable to increase the efficacy and deliverability of the particular drug. Also, the devices may be modified to promote endothelialization. Various materials and coating methodologies may be utilized to maintain the drugs, agents or compounds on the medical device until delivered and positioned. In addition, the devices utilized to deliver the implantable medical devices may be modified to reduce the potential for damaging the implantable medical device during deployment. Medical devices include stents, grafts, anastomotic devices, perivascular wraps, sutures and staples. In addition, various polymer combinations may be utilized to control the elution rates of the therapeutic drugs, agents and/or compounds from the implantable medical devices. In each of these instances, antioxidants are utilized to prolong product integrity.
Cordis Corporation
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
The use of antioxidants to prevent oxidation and reduce drug... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with The use of antioxidants to prevent oxidation and reduce drug..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and The use of antioxidants to prevent oxidation and reduce drug... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1936855